Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-24

FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for clomipramine hydrochloride submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPRAMINE HYDROCHLORIDE (clomipramine hydrochloride)

Snippet

SUPPL AP for CLOMIPRAMINE HYDROCHLORIDE (CLOMIPRAMINE HYDROCHLORIDE)